Company intelligence / Profile preview

Colbourne Pharmaceuticals

Princeton, New Jersey, United States

Ownership: Private
Development stage: Other

Overview

Colbourne Pharmaceuticals is a specialty pharmaceutical company focused on the development of improved formulations of existing central nervous system (CNS) medications. The company utilizes proprietary drug delivery technologies to enhance the pharmacokinetic profiles of established molecules, aiming to reduce side effects and improve patient compliance. Their primary focus areas include psychiatry and neurology, with a specific emphasis on antipsychotic and antidepressant treatments. Colbourne aims to bring value to patients and healthcare providers by optimizing the delivery of proven therapeutic agents.

Therapeutic areas: Psychiatry
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Colbourne Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Colbourne Pharmaceuticals.

Explore the full profile